(Q40655285)

22 September 2017

title

Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines (English)

1 reference

22 September 2017

Jennette A Sakoff

7

0 references

Adam McCluskey

object named as

Adam McCluskey

1

0 references

author name string

Stephen P Ackland

2

1 reference

22 September 2017

Michael C Bowyer

3

1 reference

22 September 2017

Monique L Baldwin

4

1 reference

22 September 2017

James Garner

5

1 reference

22 September 2017

Cecilia C Walkom

6

1 reference

22 September 2017

publication date

1 February 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

31

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

68-79

1 reference

Medical uses of mylabris in ancient China and recent studies

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

1 reference

7 January 2021

Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

The effect of cantharidin on epithelial cells in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Small molecule inhibitors of serine/threonine protein phosphatases.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

The first two cantharidin analogues displaying PP1 selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Inhibition of protein phosphatase 2A by cantharidin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-2068%2802%2900524-2

7 January 2021

10.1016/S0045-2068(02)00524-2

Identifiers

DOI

1 reference

22 September 2017

1 reference